REFERENCES
1. Boichenko V, Noakes VM, Reilly-o’donnell B, et al. Circulating non-coding RNAs as indicators of fibrosis and heart failure severity. Cells. 2025;14:553.
2. Jones NR, Roalfe AK, Adoki I, Hobbs FR, Taylor CJ. Survival of patients with chronic heart failure in the community: a systematic review and meta-analysis. Eur J Heart Fail. 2019;21:1306-25.
4. Abbas N, Perbellini F, Thum T. Non-coding RNAs: emerging players in cardiomyocyte proliferation and cardiac regeneration. Basic Res Cardiol. 2020;115:52.
5. Zhao J, Huang H. Extracellular vesicle-derived non-coding RNAs: key mediators in remodelling heart failure. Curr Issues Mol Biol. 2024;46:9430-48.
6. Li J, Han Y, Wang S, Wu X, Cao J, Sun T. Circular RNAs: biogenesis, biological functions, and roles in myocardial infarction. Int J Mol Sci. 2023;24:4233.
7. Bibi A, Bartekova M, Gandhi S, et al. ; CardioRNA COST Action CA17129 and AtheroNET COST Action CA21153. Circular RNA regulatory role in pathological cardiac remodelling. Br J Pharmacol. 2024;182:316-39.
8. Garcia-padilla C, Lozano-velasco E, Garcia-lopez V, et al. Comparative analysis of non-coding RNA transcriptomics in heart failure. Biomedicines. 2022;10:3076.
9. Wu S, Chen L, Zhou X. Circular RNAs in the regulation of cardiac hypertrophy. Molecular Therapy Nucleic Acids. 2022;27:484-90.
10. Wei L, Liu L, Bai M, Ning X, Sun S. CircRNAs: versatile players and new targets in organ fibrosis. Cell Commun Signal. 2023;21:90.
11. Xie Q, Ma Y, Ren Z, Gu T, Jiang Z. Circular RNA: a new expectation for cardiovascular diseases. J Cell Biochem. 2023;125:e30512.
12. Uzoechina J, Zhang Z. Circular RNA-encoded proteins in disease pathogenesis. Int. J. Biol. Sci. 2025;21:6179-96.
13. Yao X, Huang X, Chen J, Lin W, Tian J. Roles of non-coding RNA in diabetic cardiomyopathy. Cardiovasc Diabetol. 2024;23:227.
14. Din ZU, Xia J, Wu Z, Liao Z, Xiong X. Circular RNAs and endothelial dysfunction: mechanistic crosstalk and emerging therapeutic perspectives. Cell Mol Life Sci. 2025;83:10.
15. Sygitowicz G, Sitkiewicz D. Involvement of circRNAs in the development of heart failure. Int J Mol Sci. 2022;23:14129.
16. Hu Y, Cao H, Sheng J, et al. Functional role of circRNA CHRC through miR-431-5p/KLF15 signaling axis in the progression of heart failure. J Genet Genomics. 2024;51:844-54.
17. Lu P, Zhang D, Ding F, Ma J, Xiang YK, Zhao M. Silencing of circCacna1c inhibits ISO-induced cardiac hypertrophy through miR-29b-2-5p/NFATc1 Axis. Cells. 2023;12:1667.
18. Xie Q, Xu X, Xiong D, Yao M, Zhou Y. CircRNA Larp4b/miR-298-5p/Mef2c regulates cardiac hypertrophy induced by angiotensin II. Int J Sports Med. 2023;45:33-40.
19. Chen C, Shen H, Huang Q, Li Q. The circular RNA CDR1as regulates the proliferation and apoptosis of human cardiomyocytes through the miR-135a/HMOX1 and miR-135b/HMOX1 axes. Genet Test Mol Biomarkers. 2020;24:537-48.
20. Wang Y, Wang H, Zhang L, Zhang J, Liu N, Zhao P. A novel identified circular RNA, circSnap47, promotes heart failure progression via regulation of miR-223-3p/MAPK axis. Mol Cell Biochem. 2022;478:459-69.
21. Han J, Zhang L, Hu L, et al. Circular RNA-expression profiling reveals a potential role of Hsa_circ_0097435 in heart failure via sponging multiple microRNAs. Front. Genet. 2020;11:212.
22. Wang Z, Liu X, Deng Y. Negative feedback of SNRK to circ-SNRK regulates cardiac function post-myocardial infarction. Cell Death Differ. 2021;29:709-21.
23. Zheng H, Shi L, Tong C, Liu Y, Hou M. circSnx12 is involved in ferroptosis during heart failure by targeting miR-224-5p. Front. Cardiovasc. Med. 2021;8:656093.
24. Li B, Bai W, Guo T, et al. Statins improve cardiac endothelial function to prevent heart failure with preserved ejection fraction through upregulating circRNA-RBCK1. Nat Commun. 2024;15:2953.
25. Huang S, Li X, Zheng H, et al. Loss of super-enhancer-regulated circRNA Nfix induces cardiac regeneration after myocardial infarction in adult mice. Circulation. 2019;139:2857-76.
26. Dong K, He X, Su H, Fulton DJR, Zhou J. Genomic analysis of circular RNAs in heart. BMC Med Genomics. 2020;13:167.
27. Li F, Du WW, Li X, et al. A new protein isoform encoded by human circular RNA circSLC8a1 contributes to cardiac remodelling. Cardiovasc Res. 2025;121:882-99.
28. Zhu Y, Zheng C, Zhang R, et al. Circ-Ddx60 contributes to the antihypertrophic memory of exercise hypertrophic preconditioning. J. Adv. Res.2023;46:113-21.
29. Li C, Wang J, Feng J, et al. Circ-TLR4 promotes cardiac hypertrophy through recruiting FUS to stabilize TLR4 mRNA. J Interv Card Electrophysiol. 2022;65:153-63.
30. Feng Y, Yan B, Cheng H, et al. Knockdown circ_0040414 inhibits inflammation, apoptosis and promotes the proliferation of cardiomyocytes via miR‐186‐5p/PTEN/AKT axis in chronic heart failure. Cell Biol Int. 2021;45:2304-15.
31. Wang LL, Yao HM, Zhao XX, Yin XW, Tian JS. Knockdown of circRNA_0030042 attenuates heart failure via miR‐568/PRG4 pathway. J Biochem Mol Toxicol. 2025;39:e70267.
32. Zhang P, Liu Y, Zhan Y, et al. Circ-0006332 stimulates cardiomyocyte pyroptosis via the miR-143/TLR2 axis to promote doxorubicin-induced cardiac damage. Epigenetics. 2024;19:2380145.
33. Gao X, Liu C, Zhang Y, et al. The circRNA CNEACR regulates necroptosis of cardiomyocytes through Foxa2 suppression. Cell Death Differ. 2021;29:527-39.
34. Deng Y, Wang J, Xie G, Zeng X, Li H. Circ-HIPK3 Strengthens the effects of adrenaline in heart failure by MiR-17-3p - ADCY6 axis. Int. J. Biol. Sci. 2019;15:2484-96.
35. Bibi A, Madè A, Greco S, et al. Circular PVT1 promotes cardiac fibroblast activation interacting with miR-30a-5p and miR-125b-5p. Cell Death Dis. 2025;16:325.
36. Guo J, Chen L, Huang Z, et al. Suppression of the inhibitory effect of circ_0036176-translated Myo9a-208 on cardiac fibroblast proliferation by miR-218-5p. J Cardiovasc Transl Res. 2022;15:548-59.
37. Ji D, Jin S, Jiang Y, et al. CircNSD1 promotes cardiac fibrosis through targeting the miR-429-3p/SULF1/Wnt/β-catenin signaling pathway. Acta Pharmacol Sin. 2024;45:2092-106.
38. Zhu Y, Pan W, Yang T, et al. Upregulation of circular RNA CircNFIB attenuates cardiac fibrosis by sponging miR-433. Front. Genet. 2019;10:564.
39. Wu N, Xu J, Du WW, et al. YAP Circular RNA, circYap, attenuates cardiac fibrosis via binding with tropomyosin-4 and gamma-actin decreasing actin polymerization. Mol Ther. 2021;29:1138-50.
40. Pang P, Si W, Wu H, et al. The circular RNA circHelz enhances cardiac fibrosis by facilitating the nuclear translocation of YAP1. Transl Res. 2023;257:30-42.
41. Ma GB, Chen WX, Zhan FJ, et al. Circ_0002295 facilitated myocardial fibrosis progression through the miR‐1287/CXCR2 axis. Clin Exp Pharmacol Physiol. 2023;50:944-53.
42. Zheng H, Huang S, Wei G, et al. CircRNA Samd4 induces cardiac repair after myocardial infarction by blocking mitochondria-derived ROS output. Mol Ther. 2022;30:3477-98.
43. Ju J, Li X, Zhao X, et al. Circular RNA FEACR inhibits ferroptosis and alleviates myocardial ischemia/reperfusion injury by interacting with NAMPT. J Biomed Sci. 2023;30:45.
44. Zang J, Lu D, Xu A. The interaction of circRNAs and RNA binding proteins: an important part of circRNA maintenance and function. J Neurosci Res. 2018;98:87-97.
45. Du WW, Yang W, Chen Y, et al. Foxo3 circular RNA promotes cardiac senescence by modulating multiple factors associated with stress and senescence responses. Eur Heart J. 2016:ehw001.
46. Xu Q, Liu J, Zhu R, et al. NSD2 promotes pressure overload-induced cardiac hypertrophy via activating circCmiss1/TfR1/ferroptosis signaling. Life Sci. 2023;328:121873.
47. Zhou L, Zhai M, Huang Y, et al. The circular RNA ACR attenuates myocardial ischemia/reperfusion injury by suppressing autophagy via modulation of the Pink1/ FAM65B pathway. Cell Death Differ. 2018;26:1299-315.
48. Lim TB, Aliwarga E, Luu TDA, et al. Targeting the highly abundant circular RNA circSlc8a1 in cardiomyocytes attenuates pressure overload induced hypertrophy. Cardiovasc Res. 2019;115:1998-2007.
49. Li M, Ding W, Fang X, et al. Novel truncated peptide derived from circCDYL exacerbates cardiac hypertrophy. Circ Res. 2025;136.
50. Wei G, Li C, Jia X, et al. Extracellular vesicle-derived CircWhsc1 promotes cardiomyocyte proliferation and heart repair by activating TRIM59/STAT3/Cyclin B2 pathway. J. Adv. Res.2023;53:199-218.
51. Liu J, Yao D, Zhou F, et al. RBM24-mediated biogenesis of circ23679 protects cardiomyocytes against apoptosis via sponging miR-15b-5p. Int J Biol Macromol. 2025;310:143242.
52. Fan X, Yang Y, Chen C, Wang Z. Pervasive translation of circular RNAs driven by short IRES-like elements. Nat Commun. 2022;13:3751.
53. Xu J, Du WW, Wu N, et al. The circular RNA circNlgnmediates doxorubicin-inducedcardiac remodeling and fibrosis. Molecular Therapy - Nucleic Acids. 2022;28:175-89.
54. Du WW, Xu J, Yang W, et al. A neuroligin isoform translated by circNlgn contributes to cardiac remodeling. Circ Res. 2021;129:568-82.
55. Legnini I, Di Timoteo G, Rossi F, et al. Circ-ZNF609 is a circular RNA that can be translated and functions in myogenesis. Mol Cell. 2017;66:22-37.e9.
56. Jiang T, Xia Y, Lv J, et al. A novel protein encoded by circMAPK1 inhibits progression of gastric cancer by suppressing activation of MAPK signaling. Mol Cancer. 2021;20:66.
57. Zhang M, Huang N, Yang X, et al. A novel protein encoded by the circular form of the SHPRH gene suppresses glioma tumorigenesis. Oncogene. 2018;37:1805-14.
58. Li Z, Huang C, Bao C, et al. Exon-intron circular RNAs regulate transcription in the nucleus. Nat Struct Mol Biol. 2015;22:256-64.
59. Qin T, Li J, Zhang K. Structure, regulation, and function of linear and circular long non-coding RNAs. Front. Genet. 2020;11:150.
60. Gasparini S, Licursi V, Presutti C, Mannironi C. The secret garden of neuronal circRNAs. Cells. 2020;9:1815.
61. Chen J, Xiao X, Zhou C, Zhang Y, Rhee J, Li H. The dark side of vascular aging: noncoding ribonucleic acids in heart failure with preserved ejection fraction. Cells. 2025;14:1269.
62. Zhang J. Non-coding RNAs and angiogenesis in cardiovascular diseases: a comprehensive review. Mol Cell Biochem. 2024;479:2921-53.
63. Yang T, Long T, Du T, Chen Y, Dong Y, Huang Z. Circle the cardiac remodeling with circRNAs. Front. Cardiovasc. Med. 2021;8:702586.
64. Wang K, Long B, Liu F, et al. A circular RNA protects the heart from pathological hypertrophy and heart failure by targeting miR-223. Eur Heart J. 2016;37:2602-11.
65. Ao X, Ding W, Li X, et al. Non-coding RNAs regulating mitochondrial function in cardiovascular diseases. J Mol Med. 2023;101:501-26.
66. Zhang Y, Chen B. Silencing circ_0062389 alleviates cardiomyocyte apoptosis in heart failure rats via modulating TGF-β1/Smad3 signaling pathway. Gene. 2021;766:145154.
67. Si X, Zheng H, Wei G, et al. circRNA Hipk3 induces cardiac regeneration after myocardial infarction in mice by binding to Notch1 and miR-133a. Molecular Therapy Nucleic Acids. 2020;21:636-55.
68. Ni H, Li W, Zhuge Y, et al. Inhibition of circHIPK3 prevents angiotensin II-induced cardiac fibrosis by sponging miR-29b-3p. Int J Cardiol. 2019;292:188-96.
69. Zhang M, Wang Z, Cheng Q, et al. Circular RNA (circRNA) CDYL induces myocardial regeneration by ceRNA after myocardial infarction. Med Sci Monit. 2020;26:923188.
70. Mckinsey TA, Foo R, Anene-nzelu CG, et al. Emerging epigenetic therapies of cardiac fibrosis and remodelling in heart failure: from basic mechanisms to early clinical development. Cardiovasc Res. 2022;118:3482-98.
71. Mei S, Ma X, Zhou L, et al. CircSMAD3 represses SMAD3 phosphorylation and ameliorates cardiac remodeling by recruiting YBX1. iScience. 2024;27:110200.
72. Jeong A, Lim Y, Kook T, et al. Circular RNA circSMAD4 regulates cardiac fibrosis by targeting miR-671-5p and FGFR2 in cardiac fibroblasts. Molecular Therapy Nucleic Acids. 2023;34:102071.
73. Ma C, Wei Z, Sun T, et al. Circ-sh3rf3/GATA-4/miR-29a regulatory axis in fibroblast-myofibroblast differentiation and myocardial fibrosis. Cell Mol Life Sci. 2023;80:50.
74. Wu N, Li C, Xu B, et al. Circular RNA mmu_circ_0005019 inhibits fibrosis of cardiac fibroblasts and reverses electrical remodeling of cardiomyocytes. BMC Cardiovasc Disord. 2021;21:308.
75. Pan W, Hunkler HJ, Chatterjee S, et al. A circular RNA derived from the ryanodine receptor 2 locus controls cardiac hypertrophy and calcium handling. Cell Mol Life Sci. 2025;82:359.
76. Zhang H, Li J, Wang Y, Li Q, Song L, Li M. CircNCX1 contributes to mitochondrial fusion in cardiomyocyte by mediating the expression of mitofusin 2. Int J Biol Macromol. 2025;329:147738.
77. Xiong J, Hu Y, Liu Y, Zeng X. CircRNA mmu_circ_0000021 regulates microvascular function via the miR-143-3p/NPY axis and intracellular calcium following ischemia/reperfusion injury. Cell Death Discov. 2022;8:315.
78. Wang K, Gan T, Li N, et al. Circular RNA mediates cardiomyocyte death via miRNA-dependent upregulation of MTP18 expression. Cell Death Differ. 2017;24:1111-20.
79. Salgado-somoza A, Zhang L, Vausort M, Devaux Y. The circular RNA MICRA for risk stratification after myocardial infarction. IJC Heart & Vasculature. 2017;17:33-6.
80. Chair S, Chan J, Waye M, Liu T, Law B, Chien W. Exploration of potential genetic biomarkers for heart failure: a systematic review. Int J Environ Res Public Health. 2021;18:5904.
81. Ibrahim NE, Januzzi JL. Established and emerging roles of biomarkers in heart failure. Circ Res. 2018;123:614-29.
82. Bayoumi AS, Aonuma T, Teoh J, Tang Y, Kim I. Circular noncoding RNAs as potential therapies and circulating biomarkers for cardiovascular diseases. Acta Pharmacol Sin. 2018;39:1100-9.
83. Sun Y, Jiang X, Lv Y, et al. Circular RNA expression profiles in plasma from patients with heart failure related to platelet activity. Biomolecules. 2020;10:187.
84. Capirossi G, Brasini S, Tremoli E, Binatti A, Roncarati R. Circular RNAs in cardiovascular physiopathology: from molecular mechanisms to therapeutic opportunities. Int J Mol Sci. 2025;26:9725.
85. Bär C, Chatterjee S, Falcão Pires I, et al. Non-coding RNAs: update on mechanisms and therapeutic targets from the ESC Working Groups of Myocardial Function and Cellular Biology of the heart. Cardiovasc Res. 2020;116:1805-19.
86. Taherpour A, Ebrahimi S, Mirzavi F. A comprehensive insight into the roles of exosomal circRNAs in metabolic syndrome. Biofactors. 2025;51:e70053.
87. Wang TZ, Thapa RK, Yu F, et al. Mining, validating, and quantifying circular RNA transcriptome from total RNA as a biomarker or target. Sci Rep. 2025;15:20418.
88. Mi Z, Zhongqiang C, Caiyun J, Yanan L, Jianhua W, Liang L. Circular RNA detection methods: a minireview. Talanta. 2022;238:123066.
89. Bakhtiarizade MR, Heidari M, Ghanatghestani AHM. Comprehensive circular RNA profiling in various sheep tissues. Sci Rep. 2024;14:26238.
90. Bahrulolum H, Rouzbahani FN, Hoseini ZS, Chaharmahali M, Hosseini SM. CircRNA: unlocking new frontiers in therapeutic and vaccine development. Mol Ther. 2026;34:748-70.
91. Chyou JY, Qin H, Butler J, Voors AA, Lam CSP. Sex-related similarities and differences in responses to heart failure therapies. Nat Rev Cardiol. 2024;21:498-516.
